3Owen RG.Developing diagnostic criteria in Waldenstrom's macroglobu-linemia(J).Semin Oncol,2003;30(2):196-200.
4Kristinsson SY,Bjorkholm M,Goldin LR,et al.Risk of lymphoprolifera-tive disorders among first-degree relatives of lymphoplasm arcytic lympho-ma/Waldenstrom's macroglobulinemia patients:a population-based study in Sweden(J).Blood,2008;112(8):3052-6.
6Gertz MA.Waldenstrom's macroglobulinemia:a review of therapy(J).Am J Hematol,2005;79(2):147-57.
7Dimopoulos MA,Merlini G,Leblond V,et al.How we treat Walden-strom's macroglobulinemia(J).Hematologica,2005;90(1):117-25.
8Hoster E,Dreyling M,Eimermacher H,et al.The addition of rituximab to front-line therapy with CHOP(R-CHOP)results in a higher response rate and long time to treatment failure in patients with lymphoplasmacytic lymphoma:results of a randomized trial of the German Low-Grade Lym-phom a Study Group(GLSG)(J).Leuk Res,2009;23(1):153-61.
3Owen RG,Treon SP,Al-Katib A,et al.Clinicopathological definition of Waldenstrom's macroglobulinemia:consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia[J].Semin Oncol,2003,30(2):110-115.
4San Miguel JF,Vidriales MB,Ocio E,et al.Immunophenotypic analysis of Waldemtrom's macrogtobulinemia[J].Semin Oncol,2003,30(2):187-195.
5Sahota SS,Forconi F,Ottensmeier GH,et al.Typical Waldenstrom's macrogtobulinemia is derived from a B cell arrested after cessation of somatic mutation but prior to isotype switch events[J].Blood,2002,100(4):1505-1507.
6Moral P,Duhamel A,Gobbi P,et al.International prognostic scoring system for Waldenstrom macroglobulinemia[J].Blood,2009,113(18):4163-4170.
7Gertz MA.Waldenstrom macrogtobulinemia:a review of therapy[J].Am J Hematol,2005,79(2):147-157.
8Dimopoulos MA,Gertz MA,Kastritis E,et al.Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia[J].J Clin Oncol,2009,27(1):120-126.
10Tamburini J,Levy V,Chaleteix C,et al.Fludarabine plus cyclophosphamide in Waldenstrom's macroglobulinemia:results in 49patients[J].Leukemia,2005,19(10):1831-1834.
